Status and awareness of cervical, breast, and colon cancer screening in a Turkish city

Purpose of Investigation: Mortality and morbidity rates of cervical, breast, and colorectal cancers (CRC) can be decreased via effective screening strategies. Developing countries are to be expected to establish and implement their own programs. Materials and Methods: To evaluate regional awareness and status of cervical, breast, and CRC screening, a questionnaire-based study was conducted in 500 volunteers from a Turkish community hospital. Results: Awareness rates were 57.4% for Pap smear, 61.2% for mammography, and 25.4% for CRC. Implementation rates were 19.2%, 23.9%, and 12%, respectively. Positive family history for gynecologic cancer and past cervical ablative procedure parameters were related to higher Pap smear rates. Educational level, breast self-exam, and positive Pap smear history parameters were related to higher mammography rates. Factors related to higher colorectal cancer screening rates were nulliparity and positive Pap smear history. Conclusion: Cancer screening rates for this Turkish city are still below the expected levels despite recently revitalized national screening program. For success, it is essential not only to educate rural populations but also to train negligent healthcare providers regularly.

Cervix cancer; Breast cancer; Colorectal cancer; Cancer screening; Pap smear.

[1] International Agency for Research on Cancer, World Health Organization. Globocan 2012: “Estimated Cancer Incidence, Mortality and Prevalance Worldwide in 2012”. Available at: http://globocan.iarc.fr/Default.aspx

[2] Turkish Ministry Health, Public Healthcare Department: “The 2014 Short Report on Cancer Prevention and Screening”. Available at: http://kanser.gov.tr/ kanser/kanser-taramalari/1444-kanser-taramalarikisa-rapor-2014.html

[3] World Health Organization 2014: “Comprehensive Cervical Cancer Control, A guide to essential practice” Second Edition. Available at: http://apps.who.int/iris/bitstream/10665/144785/1/9789241548953_eng.pdf

[4] American College of Obstetricians-Gynecologists: “Practice bulletin no. 122: Breast cancer screening”. Obstet Gynecol., 2011, 118, 372.

[5] Oeffinger K.C., Fontham E.T., Etzioni R., Herzig A.: “Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society”. JAMA, 2015, 314, 1599

[6] World Health Organization: “WHO position paper on mammography screening”. 2014. Available at: http://apps.who.int/iris/bitstream/10665/137339/1/ 9789241507936_eng.pdf?ua=1&ua=1

[7] Levin B., Lieberman D.A., McFarland B., Smith R.A., Brooks D., Andrews K.S., et al.: “Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: “a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology”. CA Cancer J. Clin., 2008, 58, 130.

[8] Turkish Ministry of Health Public Health Care Department: “Cancer Early Diagnosis -Screening –Training Centers (KETEMs)” Available at: http://kanser.gov.tr/daire-faaliyetleri/ketem-ve-kanser taramalari.html

[9] Gulten G., Memnun S., Ayse K., Aygul A., Gulcin A.: “Breast, cervical, and colorectal cancer screening status of a group of Turkish women”. Asian Pac. J. Cancer Prev., 2012, 13, 4273.

[10] Guvenc G., Akyuz A., Açikel C.H.: “Health Belief Model Scale for Cervical Cancer and Pap Smear Test: psychometric testing”. J. Adv. Nurs., 2011, 67, 428.

[11] Erbil N., Tezcan Y., Gür E.N., Yildirim M., Aliş N.: “Factors affecting cervical screening among Turkish women”. Asian Pac. J. Cancer Prev., 2010, 11, 1641.

[12] Yavan T., Akyüz A., Tosun N., Iyigun E.: “Women’s breast cancer risk perception and attitudes toward screening tests”. J. Psychosoc. Oncol., 2010, 28, 189.

[13] Discigil G., Sensoy N., Tekin N., Soylemez A.: “Attitude and practice on breast health in west Anatolian women sample”. Breast J., 2007, 13, 218.

[14] Nur N.: “Breast cancer knowledge and screening behaviors of the female teachers”. Women Health, 2010, 50, 37.

[15] Bas K., Guler T., Gunay L.M., Besim H., Uygur D.: Public awareness of colorectal cancer in a Turkish population: importance of fecal occult blood testing”. Asian Pac. J. Cancer Prev., 2012, 13, 195.

[16] Dinc A.: “Pap smear screening results for Turkish pregnant women”. Asian Pac. J. Cancer Prev., 2012, 13, 5835.

[17] Mehmetoglu H.C., Sadikoglu G., Ozcakir A., Bilgel N.: “Pap smear screening in the primary health care setting: A study from Turkey”. N. Am. J. Med. Sci., 2010, 2, 467.

[18] Reis N., Bebis H., Kose S., Sis A., Engin R., Yavan T.: “Knowledge, behavior and beliefs related to cervical cancer and screening among Turkish women”. Asian Pac. J. Cancer Prev., 2012, 13, 1463.

[19] Dundar P.E., Ozyurt B.C., Erdurak K.: “Sociodemographic determinants of nonattendance in a population-based mammography screening program in the city of Manisa, Turkey”. ScientificWorldJournal, 2012, 2012, 816903.

[20] Erbil N., Bölükbaş N.: “Beliefs, attitudes, and behavior of Turkish women about breast cancer and breast self-examination according to a Turkish version of the Champion Health Belief Model Scale”. Asian Pac. J. Cancer Prev., 2012, 13, 5823.

[21] Department of Health and Human Services: “US National Health Agenda”. Available at: http://www.healthypeople.gov

[22] Centers for Disease Control and Prevention: “Cervical Cancer Screening Guidelines for Average-Risk Women”. Available at: www.cdc.gov/cancer/cervical/pdf/guidelines.pdf

[23] Huh W.K., Ault K.A., Chelmow D., Davey D.D., Goulart R.A., Garcia F.A., et al.: “Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance”. Gynecol. Oncol., 2015, 136, 178.